BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20028790)

  • 21. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.
    Tretter L; Patocs A; Chinopoulos C
    Biochim Biophys Acta; 2016 Aug; 1857(8):1086-1101. PubMed ID: 26971832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
    Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
    BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Succinate in Regulation of Immediate HIF-1α Expression in Hypoxia.
    Lukyanova LD; Kirova YI; Germanova EL
    Bull Exp Biol Med; 2018 Jan; 164(3):298-303. PubMed ID: 29308570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting the TCA cycle: signaling to tumor formation.
    Raimundo N; Baysal BE; Shadel GS
    Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
    Her YF; Nelson-Holte M; Maher LJ
    PLoS One; 2015; 10(5):e0127471. PubMed ID: 25985299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
    Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
    Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
    Desideri E; Vegliante R; Ciriolo MR
    Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expression.
    Jones R; McDonald KE; Willson JA; Ghesquière B; Sammut D; Daniel E; Harris AJ; Lewis A; Thompson AA; Dickinson RS; Plant T; Murphy F; Sadiku P; Keevil BG; Carmeliet P; Whyte MK; Newell-Price J; Walmsley SR
    Blood; 2016 May; 127(21):2641-4. PubMed ID: 27006389
    [No Abstract]   [Full Text] [Related]  

  • 30. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
    Pereira L; Soares P; Máximo V; Samuels DC
    BMC Cancer; 2012 Feb; 12():53. PubMed ID: 22299657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation.
    Schöpf B; Weissensteiner H; Schäfer G; Fazzini F; Charoentong P; Naschberger A; Rupp B; Fendt L; Bukur V; Giese I; Sorn P; Sant'Anna-Silva AC; Iglesias-Gonzalez J; Sahin U; Kronenberg F; Gnaiger E; Klocker H
    Nat Commun; 2020 Mar; 11(1):1487. PubMed ID: 32198407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma.
    Lai RK; Xu IM; Chiu DK; Tse AP; Wei LL; Law CT; Lee D; Wong CM; Wong MP; Ng IO; Wong CC
    Clin Cancer Res; 2016 Jun; 22(12):3105-17. PubMed ID: 26819450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
    Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
    Smith EH; Janknecht R; Maher LJ
    Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells.
    DeHaan C; Habibi-Nazhad B; Yan E; Salloum N; Parliament M; Allalunis-Turner J
    Mol Cancer; 2004 Jul; 3():19. PubMed ID: 15248896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free radicals-mediated damage in transmitochondrial cells harboring the T14487C mutation in the ND6 gene of mtDNA.
    Gonzalo R; Garcia-Arumi E; Llige D; Marti R; Solano A; Montoya J; Arenas J; Andreu AL
    FEBS Lett; 2005 Dec; 579(30):6909-13. PubMed ID: 16337195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonezymatic formation of succinate in mitochondria under oxidative stress.
    Fedotcheva NI; Sokolov AP; Kondrashova MN
    Free Radic Biol Med; 2006 Jul; 41(1):56-64. PubMed ID: 16781453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Oxoglutarate-dependent dioxygenases in cancer.
    Losman JA; Koivunen P; Kaelin WG
    Nat Rev Cancer; 2020 Dec; 20(12):710-726. PubMed ID: 33087883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
    Hollinshead KE; Tennant DA
    Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.
    Bedogni B; Welford SM; Cassarino DS; Nickoloff BJ; Giaccia AJ; Powell MB
    Cancer Cell; 2005 Dec; 8(6):443-54. PubMed ID: 16338658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.